ELIANA update: Tisagenlecleucel responses durable in r/r B-cell ALLDecember 2, 2018Leukemia, Myelodysplasia, Transplantation
MEDALIST: Erythroid maturation agent reduced transfusion burden in MDSDecember 1, 2018Leukemia, Myelodysplasia, Transplantation
Stem cell transplant after CAR T cells may reduce B-ALL relapse riskDecember 1, 2018Leukemia, Myelodysplasia, Transplantation
Azacitidine-nivolumab combo 'encouraging' in AMLNovember 14, 2018AMLLeukemia, Myelodysplasia, Transplantation
Variant not linked to CLL in Southeast EuropeNovember 7, 2018Leukemia, Myelodysplasia, Transplantation
Researchers consider R/R ALL drugs in the first-line settingOctober 17, 2018Leukemia, Myelodysplasia, Transplantation
Real-world clues for optimal sequencing of CLL novel agentsSeptember 25, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Pruritus linked to wide variety of cancersSeptember 16, 2018AMLLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
FDA fast-tracks CX-01 for newly diagnosed AMLSeptember 4, 2018AMLLeukemia, Myelodysplasia, Transplantation
Acute Leukemia of Ambiguous Lineage in Elderly Patients: A SEER-Medicare Database Analysis (FULL)August 10, 2018Leukemia, Myelodysplasia, Transplantation
New chronic lymphocytic leukemia guidelines from the UKAugust 8, 2018Leukemia, Myelodysplasia, TransplantationHematologyOncology
Psoriasis, Etanercept, and Myelodysplasia: Looking for ConnectionsJuly 26, 2018Leukemia, Myelodysplasia, Transplantation
Lab results may help predict complications in ALL treatmentJuly 17, 2018Leukemia, Myelodysplasia, Transplantation
Mutations may be detectable years before AML diagnosisJuly 10, 2018AMLLeukemia, Myelodysplasia, Transplantation
FDA grants regular approval to venetoclax for CLL/SLLJune 8, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
